COVID-19 Vaccine Update: Moderna Prepares for Global Launch of Coronavirus Vaccine
American biotechnology company Moderna announced that it was preparing for the global launch of its Covid-19 vaccine candidate.
Washington, Oct 30: American biotechnology company Moderna announced that it was preparing for the global launch of its Covid-19 vaccine candidate.
"We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world," Xinhua news agency quoted Moderna CEO Stephane Bancel as saying in a statement on Thursday.
In addition to the Phase 3 study of the Covid-19 vaccine mRNA-1273, which is fully enrolled, Moderna now has four programs in Phase 2 studies, according to Bancel. When Will COVID-19 Vaccine be Available? Possibly by Christmas, Says UK Govt's Taskforce Chief Kate Bingham.
"Moderna is committed to the highest data quality standards and rigorous scientific research as we continue to work with regulators to advance mRNA-1273," he said.
On October 22, the Phase 3 study of mRNA-1273 completed enrollment of 30,000 participants with approximately 37 per cent of participants from diverse communities.
The Phase 1 interim analysis of the vaccine, published in The New England Journal of Medicine on July 14, showed that mRNA-1273 was generally well-tolerated across all age groups and induced rapid and strong immune responses against SARS-CoV-2.
(The above story first appeared on LatestLY on Oct 30, 2020 10:00 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).